首页> Ophthalmology> Aryl Hydrocarbon Receptor-Interacting Protein-Like 1 in Cancer-Associated Retinopathy.

Aryl Hydrocarbon Receptor-Interacting Protein-Like 1 in Cancer-Associated Retinopathy.

导出原文传递

翻译打印收藏纠错

第一作者： Frida,Dalin

第一单位： Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Electronic address: Frida.dalin@ki.se.

作者： Frida,Dalin ^[1] ; Grazyna,Adamus ^[2] ; Sufang,Yang ^[2] ; Eva,Landgren ^[3] ; Josefine,Palle ^[4] ; Åsa,Hallgren ^[3] ; Britt-Marie,Frost ^[4] ; Therése,Hugosson ^[5] ; Nils,Landegren ^[6] ; Daniel,Eriksson ^[3] ; Sten,Andréasson ^[5] ; Khalid F,Tabbara ^[7] ; Olle,Kämpe ^[6] ; Mohammad,Alimohammadi ^[6]

作者单位： Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Electronic address: Frida.dalin@ki.se. ^[1] Ocular Immunology Laboratory, Casey Eye Institute, Oregon Health and Science University, Portland, Oregon. ^[2] Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden. ^[3] Department of Women's and Children's Health, Uppsala University Children's Hospital, Uppsala, Sweden. ^[4] Department of Clinical Sciences, Ophthalmology, Lund University, Lund, Sweden. ^[5] Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. ^[6] The Eye Center, Riyadh, Saudi Arabia. ^[7]